J. Safra Sarasin Holding AG Takes $838,000 Position in Mettler-Toledo International, Inc. $MTD

J. Safra Sarasin Holding AG purchased a new position in Mettler-Toledo International, Inc. (NYSE:MTD) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 683 shares of the medical instruments supplier’s stock, valued at approximately $838,000.

A number of other hedge funds have also bought and sold shares of MTD. Bank of New York Mellon Corp boosted its stake in shares of Mettler-Toledo International by 71.3% during the 2nd quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock worth $1,062,257,000 after purchasing an additional 376,419 shares during the period. Norges Bank purchased a new position in shares of Mettler-Toledo International during the second quarter valued at approximately $360,126,000. Rakuten Investment Management Inc. bought a new position in shares of Mettler-Toledo International during the third quarter valued at approximately $121,021,000. Corient Private Wealth LLC lifted its stake in shares of Mettler-Toledo International by 91.8% during the 2nd quarter. Corient Private Wealth LLC now owns 140,267 shares of the medical instruments supplier’s stock worth $164,775,000 after acquiring an additional 67,149 shares during the last quarter. Finally, Fiera Capital Corp boosted its holdings in Mettler-Toledo International by 19.0% during the 2nd quarter. Fiera Capital Corp now owns 342,837 shares of the medical instruments supplier’s stock valued at $402,737,000 after acquiring an additional 54,740 shares during the period. Institutional investors own 95.07% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently issued reports on MTD shares. Bank of America raised shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 target price for the company in a research note on Monday, December 15th. Citigroup upped their target price on shares of Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the stock a “buy” rating in a research note on Monday, November 10th. Morgan Stanley initiated coverage on shares of Mettler-Toledo International in a research note on Tuesday, December 2nd. They set an “equal weight” rating and a $1,550.00 price target for the company. The Goldman Sachs Group initiated coverage on Mettler-Toledo International in a research note on Tuesday, December 9th. They issued a “neutral” rating and a $1,475.00 price objective on the stock. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Mettler-Toledo International in a research report on Monday, December 29th. Six equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat, Mettler-Toledo International has a consensus rating of “Hold” and an average price target of $1,441.67.

Mettler-Toledo International Price Performance

MTD opened at $1,391.96 on Friday. The firm has a market capitalization of $28.44 billion, a PE ratio of 34.71, a price-to-earnings-growth ratio of 4.17 and a beta of 1.41. The business’s 50-day moving average is $1,433.97 and its two-hundred day moving average is $1,350.67. Mettler-Toledo International, Inc. has a 1 year low of $946.69 and a 1 year high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.20% and a negative return on equity of 426.96%. The firm had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $997.36 million. During the same quarter in the previous year, the firm earned $10.21 EPS. The company’s quarterly revenue was up 7.9% compared to the same quarter last year. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. As a group, sell-side analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Insider Activity at Mettler-Toledo International

In other Mettler-Toledo International news, CFO Shawn Vadala sold 1,895 shares of the stock in a transaction dated Tuesday, November 11th. The stock was sold at an average price of $1,455.52, for a total value of $2,758,210.40. Following the completion of the sale, the chief financial officer directly owned 5,288 shares in the company, valued at approximately $7,696,789.76. This trade represents a 26.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider La Guerroniere Marc De sold 6,880 shares of the business’s stock in a transaction dated Tuesday, November 11th. The stock was sold at an average price of $1,450.00, for a total value of $9,976,000.00. Following the sale, the insider owned 187 shares in the company, valued at $271,150. The trade was a 97.35% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 19,565 shares of company stock worth $28,683,737 over the last ninety days. Corporate insiders own 1.94% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.